Gagnon Robert E.
SEC CIK 1504983 · EDGAR
BoughtSold
Most active insiders at IRD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Foundation Fighting Blindness Retinal Degeneration Fund | Dir, See Remarks | — | $15.99M |
| 2 | Gallagher Cam | Dir | $323.9K | — |
| 3 | Magrath George | CEO, Dir | — | $204.9K |
| 4 | Gagnon Robert E. | CFO | — | $190.8K |
| 5 | YERXA BENJAMIN R | Pres, Dir | — | $61.2K |
| 6 | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | — | $58.2K |
| 7 | SCHACHLE JOSEPH K | COO | — | $57.7K |
| 8 | Zaremba Rabourn Amy | Head of Fin. Quality Assurance | — | $23.3K |
| 9 | Bennett Jean | Dir | — | — |
| 10 | Ainsworth Sean | Dir | — | — |
Transactions 34
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-08 16:05 | 2026-09-03 | IRD | Opus Genetics, Inc. | Gagnon Robert E. | CFO | S - Sale | $4.54 | -28.0K | 556.4K | -5% | -$127.2K | |
| 2026-07-27 16:06 | 2026-07-23 | IRD | Opus Genetics, Inc. | Gagnon Robert E. | CFO | S - Sale | $2.95 | -7,783 | 584.4K | -1% | -$22.9K | |
| 2026-06-11 10:02 | 2026-06-09 | HBIO | HARVARD BIOSCIENCE INC | Gagnon Robert E. | Dir | A - Grant | $0.00 | +16.6K | 27.6K | +151% | $0 | |
| 2026-04-27 16:26 | 2026-04-23 | IRD | Opus Genetics, Inc. | Gagnon Robert E. | CFO | S - Sale | $5.18 | -7,842 | 592.2K | -1% | -$40.7K | |
| 2026-01-26 | 2026-01-22 | IRD | Opus Genetics, Inc. | Gagnon Robert E. | CFO | A - Grant | $0.00 | +400.0K | 600.0K | +200% | $0 | |
| 2025-12-18 | 2025-12-16 | VSTM | Verastem, Inc. | Gagnon Robert E. | Dir | S - Sale | $9.14 | -283 | 41.7K | -0.7% | -$2,587 | |
| 2025-09-18 | 2025-09-16 | VSTM | Verastem, Inc. | Gagnon Robert E. | Dir | S - Sale | $9.99 | -281 | 42.0K | -0.7% | -$2,807 | |
| D | 2025-09-11 | 2025-09-10 | IRD | Opus Genetics, Inc. | Gagnon Robert E. | CFO | A - Grant | $0.00 | +200.0K | 200.0K | New | $0 |
| 2025-07-18 | 2025-07-16 | HBIO | HARVARD BIOSCIENCE INC | Gagnon Robert E. | Dir | A - Grant | $0.00 | +110.0K | 110.0K | New | $0 | |
| 2025-06-20 | 2025-06-16 | VSTM | Verastem, Inc. | Gagnon Robert E. | Dir | S - Sale | $5.65 | -284 | 42.2K | -0.7% | -$1,605 | |
| D | 2025-05-27 | 2025-05-22 | VSTM | Verastem, Inc. | Gagnon Robert E. | Dir | A - Grant | $0.00 | +8,333 | 42.5K | +24% | $0 |
| 2025-03-19 | 2025-03-17 | VSTM | Verastem, Inc. | Gagnon Robert E. | Dir | S - Sale | $6.95 | -284 | 34.2K | -0.8% | -$1,974 | |
| M | 2024-12-20 | 2024-12-16+ | VSTM | Verastem, Inc. | Gagnon Robert E. | Dir | S - Sale | $4.49 | -415 | 34.5K | -1% | -$1,862 |
| 2024-09-20 | 2024-09-19 | VSTM | Verastem, Inc. | Gagnon Robert E. | Dir | S - Sale | $2.79 | -131 | 34.9K | -0.4% | -$365.49 | |
| 2024-09-18 | 2024-09-16 | VSTM | Verastem, Inc. | Gagnon Robert E. | Dir | S - Sale | $2.80 | -287 | 35.0K | -0.8% | -$803.60 | |
| DM | 2024-06-20 | 2024-06-17+ | VSTM | Verastem, Inc. | Gagnon Robert E. | Dir | S - Sale | $3.40 | -414 | 35.3K | -1% | -$1,408 |
| D | 2024-06-20 | 2024-06-18 | VSTM | Verastem, Inc. | Gagnon Robert E. | Dir | A - Grant | $0.00 | +8,333 | 35.4K | +31% | $0 |
| M | 2024-03-20 | 2024-03-18+ | VSTM | Verastem, Inc. | Gagnon Robert E. | Dir | S - Sale | $10.61 | -413 | 27.4K | -1% | -$4,380 |
| 2024-02-07 | 2024-02-06 | VSTM | Verastem, Inc. | Gagnon Robert E. | Dir | S - Sale | $13.70 | -9,204 | 27.8K | -25% | -$126.1K | |
| 2024-01-17 | 2024-01-12 | VSTM | Verastem, Inc. | Gagnon Robert E. | Dir | S - Sale | $10.95 | -9,204 | 37.0K | -20% | -$100.8K | |
| M | 2023-12-20 | 2023-12-18+ | VSTM | Verastem, Inc. | Gagnon Robert E. | Dir | S - Sale | $7.67 | -414 | 46.2K | -0.9% | -$3,175 |
| M | 2023-09-20 | 2023-09-18+ | VSTM | Verastem, Inc. | Gagnon Robert E. | Dir | S - Sale | $9.89 | -408 | 46.8K | -0.9% | -$4,034 |
| M | 2023-06-21 | 2023-06-16+ | VSTM | Verastem, Inc. | Gagnon Robert E. | Dir | S - Sale | $10.04 | -413 | 47.0K | -0.9% | -$4,146 |
| M | 2023-03-20 | 2023-03-16+ | VSTM | Verastem, Inc. | Gagnon Robert E. | Dir | S - Sale | $0.4094 | -5,318 | 569.4K | -0.9% | -$2,177 |
| M | 2022-12-20 | 2022-12-16+ | VSTM | Verastem, Inc. | Gagnon Robert E. | Dir | S - Sale | $0.3969 | -13.8K | 576.1K | -2% | -$5,492 |
| 2022-09-21 | 2022-09-19 | VSTM | Verastem, Inc. | Gagnon Robert E. | CFO | S - Sale | $1.13 | -1,348 | 588.6K | -0.2% | -$1,523 | |
| 2022-06-22 | 2022-06-21 | VSTM | Verastem, Inc. | Gagnon Robert E. | CFO | S - Sale | $1.14 | -1,351 | 589.9K | -0.2% | -$1,540 | |
| 2022-05-17 | 2022-05-16 | VSTM | Verastem, Inc. | Gagnon Robert E. | CFO | S - Sale | $1.03 | -16.6K | 591.3K | -3% | -$17.1K | |
| 2022-05-17 | 2022-05-14 | VSTM | Verastem, Inc. | Gagnon Robert E. | CFO | A - Grant | $0.00 | +50.0K | 607.9K | +9% | $0 | |
| 2022-03-23 | 2022-03-21 | VSTM | Verastem, Inc. | Gagnon Robert E. | CFO | S - Sale | $1.27 | -1,409 | 557.9K | -0.3% | -$1,789 | |
| 2022-01-05 | 2022-01-03 | VSTM | Verastem, Inc. | Gagnon Robert E. | CFO | S - Sale | $2.05 | -19.6K | 559.3K | -3% | -$40.2K | |
| 2021-12-22 | 2021-12-20 | VSTM | Verastem, Inc. | Gagnon Robert E. | CFO | S - Sale | $2.27 | -5,497 | 578.9K | -0.9% | -$12.5K | |
| D | 2021-12-17 | 2021-08-12 | VSTM | Verastem, Inc. | Gagnon Robert E. | CFO | F - Tax | $2.87 | -45.3K | 435.9K | -9% | -$130.1K |
| D | 2021-12-17 | 2021-12-15 | VSTM | Verastem, Inc. | Gagnon Robert E. | CFO | A - Grant | $0.00 | +148.5K | 584.4K | +34% | $0 |
Purchase Sale Sale after option exercise All abbreviations